You are here

DEVELOPMENT OF REAGENTS FOR STEM CELL DIFFERENTIATION

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 29500
Amount: $749,999.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1998
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
7581 Lindbergh Drive
Gaithersburg, MD 20879
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Ronald Brown
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract

We will develop chemically defined reagents that support hematopoietic stem cell proliferation andSuch reagents would be valuable in hematological research especially for bone marrow transplantationex-vivo purging. Preliminary evidence indicates that it is feasible to replace the ill-defined and uwith defined chemicals. A hallmark in the progress of hematological research has been the developmenreagents. The serum-free reagents are a dramatic improvement over serum containing reagents but stilcomponents as BSA. Replacement of these ill-defined components would be of inestimable importance esdevelopment of U.S. pharmaceutical grade reagents. Typically these reagents have required the presenproducts, by-passing such components would eliminate the problems associated with blood procurementvolunteers (hepatitis, HIV, etc.) along with the time and material involved. The Phase II effort wildevelopment and optimization of chemically defined reagents for bone marrow expansion and their evalbone marrow transplantation, gene therapy and ex vivo purging.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government